ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 111 filers reported holding ACORDA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 33.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $23,000 | -30.3% | 24,165 | +48.4% | 0.00% | 0.0% |
| Q4 2019 | $33,000 | -29.8% | 16,283 | -0.2% | 0.00% | 0.0% |
| Q3 2019 | $47,000 | -55.2% | 16,308 | +19.2% | 0.00% | -50.0% |
| Q2 2019 | $105,000 | -41.7% | 13,682 | +0.8% | 0.00% | -33.3% |
| Q1 2019 | $180,000 | -14.7% | 13,569 | +0.3% | 0.00% | -25.0% |
| Q4 2018 | $211,000 | -26.2% | 13,535 | +35.9% | 0.00% | 0.0% |
| Q2 2018 | $286,000 | -80.9% | 9,956 | -84.3% | 0.00% | -81.0% |
| Q1 2018 | $1,501,000 | – | 63,454 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PFM Health Sciences, LP | 1,526,174 | $1,423,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 250,271 | $233,000 | 0.06% |
| Spark Investment Management LLC | 110,300 | $102,000 | 0.05% |
| SALZHAUER MICHAEL | 30,000 | $28,000 | 0.05% |
| HAP Trading, LLC | 260,800 | $532,000 | 0.04% |
| Point72 Asset Management, L.P. | 1,589,600 | $1,482,000 | 0.01% |
| DLD Asset Management, LP | 208,400 | $196,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 1,893,678 | $1,765,000 | 0.01% |
| EVERENCE CAPITAL MANAGEMENT INC | 65,680 | $61,000 | 0.01% |
| Benin Management CORP | 11,714 | $11,000 | 0.01% |